University of Medicine and Pharmacy Victor Babes Timisoara Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT03218280
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Novacescu Alexandru | University of Medicine and Pharmacy "Victor Babes" Timisoara | University of Medicine and Pharmacy Victor Babes Timisoara | Victor Babes University of Medicine and Pharmacy Timisoara

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 8